← All trials
NCT04120363
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2019
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pennington Biomedical Research CenterLead sponsor
- United States ArmyCollaborator
- Department of DefenseCollaborator
- University of ArkansasCollaborator
- Pennington Biomedical Research CenterOverall official - principal investigator
- Pennington Biomedical Research CenterReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.